The global preclinical imaging market is
expected to reach around USD 3.6 billion by the year 2024, according to a
report performed by Grand View Research, Inc. The swift increase in the number
of clinical research organizations (CROs), pharmaceutical companies, and
research and development organizations is propelling the demand for preclinical
imaging.
Heavy
investments in research and development are encouraging research projects
worldwide. As a result, the demand for Preclinical imaging is steadily
increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and
cosmetics are the wide application areas, where imaging modalities are widely
used in research and development. Furthermore, veterinary hospitals and
educational institutions also create an additional demand for this market.
North America
comprises the U.S. and Canada markets. North America and Europe together
accounted for the largest market share in 2015. The increased research and
development funding coupled with the presence of a highly developed research
infrastructure is accelerating the growth of the market in Europe and North
America.
On the other
hand, the governing stringent regulatory guidelines are restricting the growth
of the market in North America. Asia Pacific is expected to show the fastest
growth rate during the forecast period owing to the easy availability of
resources, the presence of an advanced research infrastructure, and the
allocation of government funds for R&D activities.
To request a
sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
- The optical imaging devices segment captured the largest market share of the overall market in 2015. The largest market share was mainly attributed to the extensive application of these devices in small animal imaging and research projects.
- The multimodal imaging devices segment is anticipated to show a significant growth rate from 2016 to 2024. The increasing adoption of these devices owing to the integration of multiple imaging modalities into a single unit is the major factor expected to drive the growth of this segment during the forecast period.
- The reagents segment accounted for a significant market share in 2015 as these products are purchased repeatedly, unlike in the case of imaging devices
- North America captured the largest market share of around 35% in 2015. The market is expected to maintain its dominance during the forecast period. Well-established research infrastructure, the growing number of research and development activities, and the rising investments in R&D are some of the factors supporting the growth of the market in this region.
- Asia Pacific is anticipated to show a significant growth rate from 2016 to 2024 owing to the rapidly expanding contract research organization (CRO) industry in this region
- The exit of the major players from the market is creating growth opportunities for the other smaller, domestic Preclinical imaging system manufacturers
- The major market players include Bruker Corporation, Siemens A.G., General Electric(GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics, Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
No comments:
Post a Comment